Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lipocalin-2 and calprotectin potential prognosis biomarkers in peripheral arterial disease

Autor: Sáenz-de-Pipaon-Echarren, G. (Goren), Ravassa, S. (Susana), Larsen, K.L. (Katrine L.), Martínez-Aguilar, E. (Esther), Orbe, J. (Josune), Rodríguez-García, J.A. (José Antonio), Fernandez-Alonso, L. (Leopoldo), González-Miqueo, A. (Aránzazu), Martin-Ventura, J.L. (José Luis), Paramo, J.A. (José Antonio), Lindholt, J.S. (Jes S.), Roncal, C. (Carmen)

Objective: Peripheral arterial disease (PAD) is the most prevalent cardiovascular (CV) condition globally. Despite the high CV risk of PAD patients, no reliable predictors of adverse clinical evolution are yet available. In this regard, previous tran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1111::c7177b62fb49be39a52cacad53349b86
https://hdl.handle.net/10171/66039

Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment

Autor: Ravassa, S, Gonzalez, A, Bayes-Genis, A, Lupon, J, Diez, J

Publikováno v: Revista Espanola de Cardiologia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Universidad de Alicante (UA)
r-IGTP: Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Myocardial interstitial fibrosis is a constant pathological finding in structural heart diseases of various etiologies that evolve with heart failure. Although fibrosis facilitates heart failure progression, until now no therapeutic strategy has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a79de27bb4640289e1cada4c7a7e85f0
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1218

Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload

Autor: Smyrnias, I. (Ioannis), Gray, S.P. (Stephen P.), Okonko, D. (Darlington), Sawyer, G. (Greta), Zoccarato, A. (Anna), Catibog, N. (Norman), Lopez-Salazar, M.B. (María Begoña), Gonzalez, A. (Arantxa), Ravassa, S. (Susana), Diez-Espino, J. (Javier), Shah, A.M. (Ajay M.)

Publikováno v: Smyrnias, I, Gray, S P, Okonko, D O, Sawyer, G, Zoccarato, A, Catibog, N, López, B, González, A, Ravassa, S, Díez, J & Shah, A M 2019, ' Cardioprotective Effect of the Mitochondrial Unfolded Protein Response During Chronic Pressure Overload ', Journal of the American College of Cardiology, vol. 73, no. 14, pp. 1795-1806 . https://doi.org/10.1016/j.jacc.2018.12.087
Journal of the American College of Cardiology
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname

Background The mitochondrial unfolded protein response (UPRmt) is activated when misfolded proteins accumulate within mitochondria and leads to increased expression of mitochondrial chaperones and proteases to maintain protein quality and mitochondri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0cc3a5dff47d6e86626ed685a674d0f1
https://kclpure.kcl.ac.uk/ws/files/110830432/1_s2.0_S0735109719306047_main.pdf